About Livzon Pharmaceutical
Livzon Pharmaceutical is a company based in Shanghai (China) founded in 1985. The company has 9,070 employees as of December 31, 2024. Livzon Pharmaceutical has completed 2 acquisitions, including Imexpharm and Livzon Group Fuzhou Fuxing Pharmaceutical. Livzon Pharmaceutical offers products and services including Injectable Drugs and Vaccines and Biologics.
- Headquarter Shanghai, China
- Employees 9070 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Livzon Pharmaceutical Group, Inc. Class A
-
Annual Revenue
$1.6 B (USD)-4.96as on Dec 31, 2024
-
Net Profit
$282.22 M (USD)5.5as on Dec 31, 2024
-
EBITDA
$435.65 M (USD)13.92as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
9070
as on Dec 31, 2024
-
Investments & Acquisitions
Imexpharm
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Livzon Pharmaceutical
Livzon Pharmaceutical is a publicly listed company on the SZSE with ticker symbol 000513 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Livzon Pharmaceutical
Livzon Pharmaceutical offers a comprehensive portfolio of products and services, including Injectable Drugs and Vaccines and Biologics.
Various injectable medications, such as Aripiprazole Microspheres, are produced for therapeutic uses in healthcare settings
Vaccines and biologic products, including recombinant proteins, are developed and supplied for disease prevention and treatment
Funding Insights of Livzon Pharmaceutical
Detailed funding history for Livzon Pharmaceutical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Livzon Pharmaceutical
Livzon Pharmaceutical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Imexpharm and Livzon Group Fuzhou Fuxing Pharmaceutical.
Investment portfolio details for Livzon Pharmaceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diversified generic drugs are manufactured by Imexpharm in Vietnam.
|
Locked | Locked | 1983 | Locked | |
|
API and intermediates for antibiotics and food additives are manufactured.
|
Locked | Locked | 1979 | Locked |
Complete acquisition details for Livzon Pharmaceutical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Livzon Pharmaceutical
Detailed financials for Livzon Pharmaceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Livzon Pharmaceutical Comparisons
Peer comparison for Livzon Pharmaceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Livzon Pharmaceutical
Detailed competitors of Livzon Pharmaceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Livzon Pharmaceutical
Complete news archive for Livzon Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Livzon Pharmaceutical
Livzon Pharmaceutical was founded in 1985.
Livzon Pharmaceutical is headquartered in Shanghai, China.
Desheng Tao is the current CEO of Livzon Pharmaceutical.
As of Dec 31, 2024, the latest employee count at Livzon Pharmaceutical is 9,070.
Annual revenue of Livzon Pharmaceutical is $1.6B as on Dec 31, 2024.
Livzon Pharmaceutical was established in 1985 and is based in Shanghai, China. Operations focus on the pharmaceutical sector, where drug preparations, bulk medicines, intermediates, diagnostic reagents, and equipment are produced. A portfolio of products is maintained for gastrointestinal, cardio-cerebral-vascular, antibiotic, gonadotropic hormone, and blood and hemopoietic system applications. The company serves these areas through its manufacturing activities.
Livzon Pharmaceutical offers Injectable Drugs and Vaccines and Biologics.
Yes, Livzon Pharmaceutical is publicly traded on SZSE under the ticker symbol 000513.
Livzon Pharmaceutical has made 2 acquisitions, including Imexpharm, and Livzon Group Fuzhou Fuxing Pharmaceutical.
The ticker symbol of Livzon Pharmaceutical is 000513 on SZSE.